Testing effectiveness (Phase 2)UnknownNCT00039156What this trial is testingBAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Theradex
Early research (Phase 1)Ended earlyNCT00112619What this trial is testingTopotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsWho this might be right forBrain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more Pediatric Brain Tumor Consortium 19
Early research (Phase 1)Study completedNCT00513474What this trial is testingRasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Massachusetts General Hospital 46
Early research (Phase 1)Ended earlyNCT02109224What this trial is testingIbrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV InfectionWho this might be right forAdult B Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaCutaneous B-Cell Non-Hodgkin Lymphoma+26 more National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)UnknownNCT00003163What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell CancersWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm Medical College of Wisconsin 10
Large-scale testing (Phase 3)Study completedNCT00719563What this trial is testingAmerican Ginseng in Treating Patients With Fatigue Caused by CancerWho this might be right forChronic Myeloproliferative DisordersFatigueLeukemia+7 more Alliance for Clinical Trials in Oncology 364
Not applicableStudy completedNCT00098566What this trial is testingLong-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaQuality of Life Fred Hutchinson Cancer Center 36
Early research (Phase 1)UnknownNCT00008021What this trial is testingMonoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT00014209What this trial is testingCombination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous TreatmentWho this might be right forLymphoma NCIC Clinical Trials Group 77
Testing effectiveness (Phase 2)Ended earlyNCT00290706What this trial is testingA Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University 32
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT00134017What this trial is testingCombination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 142
Testing effectiveness (Phase 2)Study completedNCT00589563What this trial is testingSirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+8 more City of Hope Medical Center 32
Not applicableLooking for participantsNCT01137643What this trial is testingTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more UNC Lineberger Comprehensive Cancer Center 15,000
Early research (Phase 1)UnknownNCT00009776What this trial is testingMonoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00006340What this trial is testingGanciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr VirusWho this might be right forLeukemiaLymphomaPrecancerous Condition+1 more Boston Medical Center
Not applicableLooking for participantsNCT01137825What this trial is testingRegistry of Older Patients With CancerWho this might be right forChronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemia+6 more UNC Lineberger Comprehensive Cancer Center 3,000
Early research (Phase 1)Study completedNCT00040950What this trial is testingBiological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003397What this trial is testingPeripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Maryland, Baltimore 25